Followers | 31 |
Posts | 3379 |
Boards Moderated | 0 |
Alias Born | 02/09/2017 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 23, 2020 8:43:01 PM
but here are few things you may want to know.
Lentz and Staehelin is a very big law firm. They are extremely well connected in the World.
Astrazenca protien based vaccine is much like Baylor College of Medicines. Their results look good for them.
What does Mymetics bring to the table?
1. MACIVIVA project
https://cordis.europa.eu/article/id/287491-developing-a-thermostable-needlefree-vaccine
This will help get the Vaccine delivered anywhere in the world. Shelf life is much longer as well.
2. Recent Allergy study. Why it is significant?
COP-virosomes were the only synthetic therapy able to fully reverse asthma symptoms
as well as lung inflammation (i.e. significant reduction in eeosinophils in bronchial
fluids). Pro-allergic immune responses also decreased with COP-virosome therapy
with a significant decrease of the IL-4, a Th2 cytokine. The results of the study will soon
be published.
What is Covids biggest issue? Lung inflammation. We reverse that effect.
3. We are due news on Our HIV vaccine. That could be significant.
4. We are involved with a couple Oncology companies and we were to see some results from those as well but Covid has slowed that process for now.
5. Malaria-vaccine is also on the back burner till we get covid under control although some funding has come through for PATH which our CEO Kempers has applied or is applying for to continue Phase 1,2.
6. Our delivery Mechanism could soon be used across multiple diseases. Time will tell but between Mario Amacker, Sylvain Fleury, and Toon Stegmann we are in very capable hands.
These are facts and in my opinion because of them we will soon see whether we are going to see the fruits of their labor or not. I for one can't wait to see the Baylor results cause those will be very telling. Good luck to you and all who are in this for the long haul.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM